Company Filing History:
1 out of 19 
1 out of 832,912 Years Active: 2008-2010
Title: Bobby Soni: Innovator in PEGylated G-CSF Polypeptides
Introduction
Bobby Soni is a notable inventor based in Kgs. Lyngby, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of PEGylated G-CSF polypeptides. With a total of two patents to his name, Soni's work focuses on enhancing the stability and uniformity of these important therapeutic proteins.
Latest Patents
Bobby Soni's latest patents include innovative methods for improving PEGylated G-CSF polypeptides. One patent describes compositions comprising positional isomers of PEGylated G-CSF. This method involves subjecting the polypeptide to an elevated pH above 8.0 to remove PEG moieties attached to a hydroxyl group, followed by reducing the pH to about 8.0 or lower. The second patent outlines similar methods for increasing the stability and uniformity of PEGylated G-CSF polypeptides, which are crucial for increasing neutrophil levels in patients.
Career Highlights
Throughout his career, Bobby Soni has worked with various companies, including Maxygen Holdings Ltd. His expertise in biochemistry and innovative approaches to protein modification have positioned him as a key figure in his field.
Collaborations
Bobby has collaborated with notable professionals such as Carsten Germansen and Grethe Norskov Rasmussen. Their combined efforts have contributed to advancements in the understanding and application of PEGylated proteins.
Conclusion
Bobby Soni's contributions to the field of biochemistry, particularly through his patents on PEGylated G-CSF polypeptides, highlight his innovative spirit and dedication to improving therapeutic options for patients. His work continues to influence the development of more effective treatments in the medical field.